Detalhe da pesquisa
1.
Effectiveness of antibacterial therapeutic clothing vs. nonantibacterial therapeutic clothing in patients with moderate-to-severe atopic dermatitis: a randomized controlled observer-blind pragmatic trial (ABC trial).
Br J Dermatol
; 190(3): 342-354, 2024 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37936331
2.
Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the daily practice BioDay registry.
J Am Acad Dermatol
; 2024 Apr 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38653344
3.
Dupilumab has a profound effect on specific-IgE levels of several food allergens in atopic dermatitis patients.
Allergy
; 78(3): 875-878, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36420598
4.
Ocular surface disease is common in moderate-to-severe atopic dermatitis patients.
Clin Exp Allergy
; 52(6): 801-805, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35294787
5.
Biologicals for pediatric patients with atopic dermatitis: practical challenges and knowledge gaps.
J Dermatolog Treat
; 34(1): 2254567, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37664977
6.
The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis.
Clin Transl Allergy
; 13(1): e12219, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36705510